This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revision | Last revisionBoth sides next revision | ||
home:symptoms:gastrointestinal [12.21.2018] – [Bleeding from bowel] sallieq | home:symptoms:gastrointestinal [03.13.2019] – [Bleeding from bowel] sallieq | ||
---|---|---|---|
Line 59: | Line 59: | ||
{{tag> | {{tag> | ||
+ | |||
+ | ==== Further researxh ==== | ||
+ | |||
+ | Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely. | ||
+ | |||
+ | In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity. | ||